Correlation Between SBF 120 and Abionyx Pharma
Specify exactly 2 symbols:
By analyzing existing cross correlation between SBF 120 and Abionyx Pharma SA, you can compare the effects of market volatilities on SBF 120 and Abionyx Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SBF 120 with a short position of Abionyx Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of SBF 120 and Abionyx Pharma.
Diversification Opportunities for SBF 120 and Abionyx Pharma
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between SBF and Abionyx is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding SBF 120 and Abionyx Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abionyx Pharma SA and SBF 120 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SBF 120 are associated (or correlated) with Abionyx Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abionyx Pharma SA has no effect on the direction of SBF 120 i.e., SBF 120 and Abionyx Pharma go up and down completely randomly.
Pair Corralation between SBF 120 and Abionyx Pharma
Assuming the 90 days trading horizon SBF 120 is expected to generate 0.34 times more return on investment than Abionyx Pharma. However, SBF 120 is 2.92 times less risky than Abionyx Pharma. It trades about 0.03 of its potential returns per unit of risk. Abionyx Pharma SA is currently generating about 0.0 per unit of risk. If you would invest 576,056 in SBF 120 on October 24, 2024 and sell it today you would earn a total of 10,853 from holding SBF 120 or generate 1.88% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
SBF 120 vs. Abionyx Pharma SA
Performance |
Timeline |
SBF 120 and Abionyx Pharma Volatility Contrast
Predicted Return Density |
Returns |
SBF 120
Pair trading matchups for SBF 120
Abionyx Pharma SA
Pair trading matchups for Abionyx Pharma
Pair Trading with SBF 120 and Abionyx Pharma
The main advantage of trading using opposite SBF 120 and Abionyx Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SBF 120 position performs unexpectedly, Abionyx Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abionyx Pharma will offset losses from the drop in Abionyx Pharma's long position.SBF 120 vs. Invibes Advertising NV | SBF 120 vs. Hoteles Bestprice SA | SBF 120 vs. Sartorius Stedim Biotech | SBF 120 vs. Union Technologies Informatique |
Abionyx Pharma vs. Biophytis SA | Abionyx Pharma vs. Gensight Biologics SA | Abionyx Pharma vs. OSE Pharma SA | Abionyx Pharma vs. Abivax SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |